Investigation of the efficiency and safety of half-dose and full-dose tissue plasminogen activator therapy in pulmonary embolism
Tuberk Toraks · 2025
DOI: 10.5578/tt.2025031029 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tuberk Toraks, 2025. Verfasst von Kerim Karaduman und 4 weiteren Autor:innen. Beteiligte Einrichtung: Clinic of Chest Disease, Kayseri City Hospital, Kayseri, Türkiye. Hauptthemen laut MEDLINE: Pulmonary Embolism, Tissue Plasminogen Activator, Fibrinolytic Agents, Thrombolytic Therapy.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Clinic of Chest Disease, Kayseri City Hospital, Kayseri, Türkiye.
- Department of Chest Disease, Erciyes University Faculty of Medicine, Kayseri, Türkiye.
Zitieren
APA
Karaduman, K., Tutar, N., Baran, B., Yetkin, N. A., & Gülmez, İ. (2025). Investigation of the efficiency and safety of half-dose and full-dose tissue plasminogen activator therapy in pulmonary embolism. Tuberk Toraks. https://doi.org/10.5578/tt.2025031029
Vancouver
Karaduman K, Tutar N, Baran B, Yetkin NA, Gülmez İ. Investigation of the efficiency and safety of half-dose and full-dose tissue plasminogen activator therapy in pulmonary embolism. Tuberk Toraks. 2025. doi:10.5578/tt.2025031029
BibTeX
@article{Karaduman2025,
author = {Karaduman, Kerim and Tutar, Nuri and Baran, Burcu and Yetkin, Nur Aleyna and Gülmez, İnci},
title = {Investigation of the efficiency and safety of half-dose and full-dose tissue plasminogen activator therapy in pulmonary embolism},
journal = {Tuberk Toraks},
year = {2025},
doi = {10.5578/tt.2025031029}
}
EUVIMED